# Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors

> **NCT02519712** · NA · TERMINATED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 4 (actual)

## Conditions studied

- Acute Myeloid Leukemia (AML)

## Interventions

- **DRUG:** Induction Chemotherapy
- **PROCEDURE:** G-PBSC Infusion

## Key facts

- **NCT ID:** NCT02519712
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07-28
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Lack of accrual
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02519712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02519712, "Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02519712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*